Page 11 – PRECISIONheor

On-demand Webinar: A Novel Method to Improve Validity and Relevance Of Indirect Comparisons and Network Meta-Analysis

Watch PRECISIONheor’s Jeroen Jansen, and partner David Phillippo, as they provide an introduction to a novel method, called multilevel network meta-regression (ML-NMR). The method addresses several limitations with current methods, including synthesizing networks of any size and availability of IPD or aggregate studies, and – crucially for decision-making – producing estimates in any target population of interest.

LEARN MORE

On-demand Webinar: A Novel Method to Improve Validity and Relevance Of Indirect Comparisons and Network Meta-AnalysisAlex Denk2020-10-13T11:18:59-04:00

Welcome: Hema Viswanathan, PhD

Precision is excited to welcome Hema Viswanathan as Vice President, PRECISIONheor. With more than 15 years experience in the industry, Hema brings exceptional insights and strategic vision. Hema will support cross functions in health economics and outcomes research (HEOR) from RWE, Evidence Synthesis and Modeling. Welcome to the Precision team!

LEARN MORE

Welcome: Hema Viswanathan, PhDAlex Denk2020-09-01T09:30:41-04:00

On-demand Webinar: Using HEOR Methods to Reduce Health Inequalities

Moderated by Precision's Kelly Wilder, EVP, Strategic Business Development, PRECISIONheor’s Jason Shafrin, PhD, and Meena Venkatachalam, MSc, discuss their recently published blog in Health Affairs

LEARN MORE

On-demand Webinar: Using HEOR Methods to Reduce Health InequalitiesAlex Denk2020-12-04T09:38:02-05:00

Creating Incentives To Narrow The Gap In Health Outcomes: Expanding Value Assessment To Incorporate Health Inequality

Adding to the ongoing national dialogue on racial inequality, PRECISIONheor’s Jason Shafin and Meena Venkatachalam join the conversation in their Health Affairs blog post: “Creating Incentives To Narrow The Gap In Health Outcomes: Expanding Value Assessment To Incorporate Health Inequality”.

LEARN MORE

Creating Incentives To Narrow The Gap In Health Outcomes: Expanding Value Assessment To Incorporate Health InequalityAlex Denk2020-08-06T12:40:59-04:00

COVID-19 Pandemic Vindicates the ISPOR Value Flower

ISPOR's “value flower” versus the traditional QALYs approach: Precision's Jason Shafrin, Kathy Lang and Ross Maclean discuss why the “value flower” model can more accurately value treatments - in cases like COVID-19 - which have a transformational impact on the lives of not only of patients, but also caregivers, employers, and broader society.

LEARN MORE

COVID-19 Pandemic Vindicates the ISPOR Value FlowerAlex Denk2020-07-17T15:19:36-04:00

Congratulations to Precision’s Jason Shafrin!

For the third consecutive year, Jason's blog, Healthcare Economist, has been listed as one of the Top 100 Economics Blogs by Intelligent Economist.

LEARN MORE

Congratulations to Precision’s Jason Shafrin!Alex Denk2020-07-17T15:12:45-04:00

Real-World Data Will Continue to Provide Real Value to the Drug Development and Commercialization Process

Precision's Sajjad Raza and Kathy Lang identify emerging trends that suggest the use of real-world data will continue to grow and become pivotal, and the inherent challenges that must be addressed.

LEARN MORE

Real-World Data Will Continue to Provide Real Value to the Drug Development and Commercialization ProcessAlex Denk2020-07-17T15:07:28-04:00

On-demand Webinar: Improving evidence synthesis methods

Moderated by Precision's Ross Maclean, Dr. Jeroen Jansen and Shannon Cope share their unique perspectives and solutions to tackling today's evidence synthesis and economic modeling challenges.

LEARN MORE

On-demand Webinar: Improving evidence synthesis methodsAlex Denk2020-10-13T11:20:47-04:00

The role of COVID-19 antibody testing for employers

As employers consider including COVID-19 testing as part of their reopening plans, Precision experts Jacquelyn Chou, Caroline Huber and Jennifer Millard discuss the two key issues that must be resolved before antibody testing can be truly useful for an employer.

LEARN MORE

The role of COVID-19 antibody testing for employersAlex Denk2020-05-27T15:45:56-04:00

What can Linux and Mozilla teach ICER about how to do drug value assessments?

Precision's Jason Shafrin discusses the four major challenges to ICER's approach to value-based price recommendations, and how an open source approach could overcome these challenges.

LEARN MORE

What can Linux and Mozilla teach ICER about how to do drug value assessments?Alex Denk2020-05-05T17:48:17-04:00